Chemomab Therapeutics Ltd. Investment Income
Chemomab Therapeutics Ltd. (CMMB) reported Investment Income of $42.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Income Statement › Other Income
ifrs-full:InvestmentIncome · last filed 2019-04-24
| Period end | Investment Income 12 month |
|---|---|
| 2018-12-31 | $42.00K 20-F · filed 2019-04-24 |
| 2017-12-31 | $1.00K 20-F · filed 2019-04-24 |
| 2016-12-31 | $1.00K 20-F · filed 2019-04-24 |